References
- Keefe DM, Brealey J, Goland GJ, Cummins AG: Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47, 632–637, 2000.
- Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, et al.: The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98, 1531–1539, 2003.
- Vunta H, Belda BJ, Arner RJ, Channa Reddy C, Vanden Heuvel JP, et al.: Selenium attenuates pro-inflammatory gene expression in macrophages. Mol Nutr Food Res 52, 1316–1323, 2008.
- Jahangard-Rafsanjani Z, Gholami K, Hadjibabaie M, Shamshiri AR, Alimoghadam K, et al.: The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial. Bone Marrow Transplant 48, 832–836, 2013.
- Kissow H, Hartmann B, Holst JJ, Poulsen SS: Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis. Gut 62, 1724–1733, 2013.
- Agay D, Sandre C, Ducros V, Faure H, Cruz C, et al.: Optimization of selenium status by a single intraperitoneal injection of Se in Se-deficient rat: possible application to burned patient treatment. Free Radic Biol Med 39, 762–768, 2005.
- Cool JC, Dyer JL, Xian CJ, Butler RN, Geier MS, et al.: Pretreatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats. Growth Horm IGF Res 15, 72–82, 2005.
- Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, et al.: Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemoth Pharm 63, 239–251, 2009.
- Kissow H, Viby NE, Hartmann B, Holst JJ, Timm M, et al.: Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine. Cancer Chemoth Pharm 70, 39–48, 2012.
- Logan R, Stringer A, Bowen J, Yeoh A, Gibson R, et al.: The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev 33, 448–460, 2007.
- Stringer A, Gibson R, Bowen J, Logan R, Ashton K, et al.: Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. Int J Exp Pathol 90, 489–499, 2009.
- Stringer A, Gibson R, Logan R, Bowen J, Yeoh A, et al.: Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis. Exp Biol Med (Maywood) 234, 430–441, 2009.
- Vliet M, Harmsen H, de Bont E, Tissing W: The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog 27, e1000879, 2010.
- Sausville EA, Longo DL. Chapter 85. Principles of cancer treatment. Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 689–711, 2012.
- Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, et al.: Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100, 1995–2025, 2004.
- Tomimatsu T, Horie T: Enhanced glucose absorption in the rat small intestine following repeated doses of 5-fluorouracil. Chem Biol Interact 155, 129–139, 2005.
- Melo M, Brito G, Soares R, Carvalho S, Silva J, et al.: Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide. Cancer Chemother Pharmacol 61, 775–784, 2008.
- Huang TY, Chu HC, Lin YL, Ho WH, Hou HS, et al.: Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model. Biochem Biophys Res Commun 389, 634–639, 2009.
- Wu ZQ, Han XD, Wang Y, Yuan KL, Jin ZM, et al.: Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice. Cancer Chemother Pharmacol 68, 87–96, 2011.
- Yeung CY, Chan WT, Jiang CB, Cheng ML, Liu CY, et al.: Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model. PLoS One 10, e0138746, 2015.
- Zhu JH, Zhang X, McClung JP, Lei XG: Impact of Cu, Zn-superoxide dismutase and Se-dependent glutathione peroxidase-1 knockouts on acetaminophen-induced cell death and related signaling in murine liver. Exp Biol Med (Maywood) 231, 1726–1732, 2006.
- Sunde RA, Evenson JK, Thompson KM, Sachdev SW: Dietary selenium requirements based on glutathione peroxidase-1 activity and mRNA levels and other Se-dependent parameters are not increased by pregnancy and lactation in rats. J Nutr 135, 2144–50, 2005.
- Gong G, Meplan C, Gautrey H, Hall J, Hesketh JE: Differential effects of selenium and knock-down of glutathione peroxidases on TNFalpha and flagellin inflammatory responses in gut epithelial cells. Genes Nutr 7, 167–178, 2012.
- Conklin KA: Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37, 1–18, 2000.
- Ozbal S, Erbil G, Kocdor H, Tugyan K, Pekcetin C, et al.: The effects of selenium against cerebral ischemia-reperfusion injury in rats. Neurosci Lett 438, 265–269, 2008.
- Soares PM, Mota JM, Souza EP, Justino PF, Franco AX, et al.: Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4. Cytokine 61, 46–49, 2013.
- Kim Y, Kim DC, Cho ES, Ko SO, Kwon Wy, et al.: Antioxidant and anti-inflammatory effects of selenium in oral buccal mucosa and small intestinal mucosa during intestinal ischemia-reperfusion injury. J Inflamm 11, 36, eCollection 2014.
- Sakai H, Sagara A, Matsumoto K, Hasegawa S, Sato K, et al.: 5-Fluorouracil induces diarrhea with changes in the expression of inflammatory cytokines and aquaporins in mouse intestines. PLoS ONE 8, e54788, 2013.